Creative Planning Buys 704 Shares of Chemed Co. (NYSE:CHE)

Creative Planning increased its stake in shares of Chemed Co. (NYSE:CHE) by 57.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,932 shares of the company’s stock after buying an additional 704 shares during the quarter. Creative Planning’s holdings in Chemed were worth $1,161,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Kayne Anderson Rudnick Investment Management LLC grew its stake in Chemed by 2.6% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company’s stock worth $314,868,000 after buying an additional 14,651 shares during the last quarter. William Blair Investment Management LLC grew its position in Chemed by 2.7% during the 2nd quarter. William Blair Investment Management LLC now owns 475,372 shares of the company’s stock worth $257,927,000 after acquiring an additional 12,705 shares during the last quarter. Impax Asset Management Group plc increased its holdings in Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after purchasing an additional 51,974 shares in the last quarter. TD Asset Management Inc raised its position in Chemed by 10.9% in the 2nd quarter. TD Asset Management Inc now owns 282,753 shares of the company’s stock valued at $153,416,000 after purchasing an additional 27,800 shares during the last quarter. Finally, Epoch Investment Partners Inc. boosted its stake in Chemed by 22.1% in the second quarter. Epoch Investment Partners Inc. now owns 223,134 shares of the company’s stock worth $121,068,000 after purchasing an additional 40,358 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $569.63, for a total transaction of $1,139,260.00. Following the transaction, the chief executive officer now directly owns 105,735 shares in the company, valued at approximately $60,229,828.05. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Andrea R. Lindell sold 831 shares of the firm’s stock in a transaction dated Friday, August 16th. The stock was sold at an average price of $571.51, for a total value of $474,924.81. Following the transaction, the director now owns 5,725 shares in the company, valued at $3,271,894.75. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $569.63, for a total value of $1,139,260.00. Following the sale, the chief executive officer now directly owns 105,735 shares of the company’s stock, valued at $60,229,828.05. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,144 shares of company stock worth $4,141,679. 3.32% of the stock is currently owned by corporate insiders.

Chemed Stock Performance

Shares of NYSE:CHE opened at $540.51 on Friday. The business has a fifty day moving average of $586.71 and a 200-day moving average of $569.04. Chemed Co. has a twelve month low of $525.36 and a twelve month high of $654.62. The firm has a market cap of $8.13 billion, a PE ratio of 27.31, a price-to-earnings-growth ratio of 2.44 and a beta of 0.44.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.